Chromogenex PLC is the UK’s  leading developer and manufacturer of laser and intense pulsed light (IPL) systems.

Since 1985, Chromogenex PLC has been at the forefront of laser and light technology for aesthetic applications such as hair removal, skin rejuvenation, acne and vascular lesions.

In 1994, the company developed and patented the world’s first Ruby laser for permanent hair reduction.

In 1998, we introduced the patented Nlite laser, the first laser to receive FDA clearance for wrinkle reduction and in 2000 we were the first company to receive FDA Approval for Inflammatory acne vulgaris, working with some of the world’s leading Dermatologists and Clinical Researchers.
 Video Introduction

Chromogenex PLC. operates a quality system that meets the European Medical Device Directives and United States FDA cGMP.

We have successfully distributed our devices throughout the World, meeting all product, system and regulatory requirements. We are currently accredited by our notified body SGS UK Ltd to ISO 13485-2003.

We pride ourselves on our product quality, ensuring each device has been designed for Quality, Assembly and Service with pre-launch risk assessments, Validation and 100% final test.